Cartesian Therapeutics
RNAC
RNAC
67 hedge funds and large institutions have $37.2M invested in Cartesian Therapeutics in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3.2% less ownership
Funds ownership: 23.05% → 19.85% (-3.2%)
39% less capital invested
Capital invested by funds: $60.9M → $37.2M (-$23.7M)
Holders
67
Holding in Top 10
–
Calls
$309K
Puts
$266K
Top Buyers
| 1 | +$1.39M | |
| 2 | +$1.12M | |
| 3 | +$801K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$755K |
| 5 |
Two Sigma Investments
New York
|
+$738K |
Top Sellers
| 1 | -$6.38M | |
| 2 | -$5.76M | |
| 3 | -$3.88M | |
| 4 |
BlackRock
New York
|
-$321K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$286K |
